SC3 Research Pasadena

Pasadena, California 91105

1 studies enrolling now · 8 studies all time

What they study most

Alzheimer Disease, Constipation, Essential Tremor, Generalized Myasthenia Gravis, Multiple Sclerosis, Parkinson Disease, Relapsing Multiple Sclerosis

Studies at this site

• A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. — Recruiting now
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) — Completed
• Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations — Completed
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover) — Stopped early
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) — Completed
• Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) — Stopped early